FDA clearance enables initiation of a planned Phase 1 clinical study evaluating local intravesical administration of UGN-501, with patient ...
Bladder cancer continues to be one of the most frequently diagnosed malignancies worldwide, with current treatments such as surgery and chemotherapy often ...
The government acknowledges downwinders throughout Utah, Idaho and New Mexico, as well as parts of Arizona, Nevada and ...
Later, a nurse disclosed to her that the baby was actually decapitated during labor because the doctor was pulling so hard, ...
Bored Panda on MSN
53 times doctors realized something had gone terribly wrong
Surgeries on the wrong part of the body, medicine administered in the wrong doses, and failures to listen to patients — these ...
The FDA has approved two immunotherapy combination therapies for adults with muscle-invasive bladder cancer. Pembrolizumab ...
The increasingly more popular combination of Padcev and Keytruda has expanded its bladder cancer territory once again. | The ...
The Food and Drug Administration approved a combination treatment by Merck & Co., Pfizer, and Astellas Pharma for a hard-to-treat form of bladder cancer. The agency greenlit Merck's Keytruda and its ...
The FDA approved pembrolizumab (Keytruda) or pembrolizumab and berahyaluronidase alfa (Keytruda Qlex) in combination with ...
When it comes to bladder cancer, it’s important to note the differences between muscle-invasive and non-muscle-invasive bladder cancer, as it can affect the staging of the cancer. The “stage” (spread) ...
Rice can carry a risk: inorganic arsenic, a dangerous form of a heavy metal and known carcinogen.
On Friday, the U.S. Food and Drug Administration (FDA) approved Pfizer Inc.’s PFE and Astellas Pharma Inc.’s ALPMF ALPMY ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results